Location: Home
  • search
  • go
  • Relate News
  • 7/8/2020GSK Files New Drug Application for IL-5 mAb Nucala (Mepolizumab) in Ch...
  • 7/8/2020Swiss Re: Chinese Online Health Insurance Market to Grow 43% Annually ...
  • 7/8/2020Sinovac Begins Phase III Trial of Its Coronavirus Vaccine in Brazil
  • 7/8/2020NMPA Issues Working Procedures for Drug Marketing Evaluation and Appro...
  • 7/7/2020Turning Point and Zai Lab Announce Exclusive License Deal for Repotrec...
  • 7/7/2020SinoPharm Completes New Vaccine Plant in Wuhan, Doubling Capacity
  • 7/6/2020Ascentage and MSD in Clinical Trial Partnership to Evaluate APG-115 in...
  • 7/6/2020CDE Solicits Comments on the Draft Writing Guide and Common Format of ...
  • 7/6/2020CDE Solicits Comments on the Draft Technical Guidelines for Marketing ...
  • 7/6/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...
  • 7/6/2020NPC Solicits Comments on 2nd Draft of the Chinese Patent Law Amendment...
  • 7/3/2020CDE Issues Interim Guidelines for Registration Acceptance and Evaluati...
  • 7/3/2020GSK Launches Shingles Vaccines Shingrix in China
  • 7/3/2020Boehringer Ingelheim Launches Innovation Hub in Shanghai
  • 7/2/2020NMPA and NHC Introduce the 2020 Edition of Chinese Pharmacopoeia
  • 7/2/2020NIFDC Issues the Guideline for the Working Procedures and Technical Re...
  • 7/2/2020Senior Chinese Pharma Official Investigated for Serious Legal Violatio...
  • 7/2/2020NMPA Issues the Amended Blood Product Appendix of 2010 GMP
  • 7/1/2020Revisiting the Basis of Your China Strategy in the Post-Covid New Norm...
  • 7/1/2020Trends in U.S. Multinational Enterprise Activity in China, 2000-2017
  • 7/1/2020CDE Solicits Comments on the Draft CDE Guidelines for Management of Su...
  • 7/1/2020CDE Issues the M4 Module 1. Administrative Information and Prescribing...
  • 7/1/2020CDE Issues the Guidelines for Evaluation and Management of Safety Info...
  • 7/1/2020CDE Issues the Guidelines for Clinical Trial Registration and Informat...
  • 7/1/2020NMPA Reports on Crackdown of Fake and Substandard Drugs in 2019
  • 7/1/2020China's First COVID-19 mRNA Vaccine Approved for Clinical Trials
  • 7/1/2020Financial-related Company News in Brief
  • 7/1/2020ObsEva and Yuyuan Bio Announce Submission of Chinese Pre-IND Dossier f...
  • 7/1/2020NMPA Issues Announcement on Drug Registration Fee Standards and Rules
  • 7/1/2020NMPA Issues the Requirements for Drug Record and Data Management (Inte...
  • Page:246/790 Total number of articles:23678: [First][<<] [244] [245] [246] [247] [248] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group